NO902899L - Fremgangsmaate for enzymbasert immunologisk analyse av et antigen samt fast fase for anvendelse ved fremgangsmaaten. - Google Patents

Fremgangsmaate for enzymbasert immunologisk analyse av et antigen samt fast fase for anvendelse ved fremgangsmaaten.

Info

Publication number
NO902899L
NO902899L NO90902899A NO902899A NO902899L NO 902899 L NO902899 L NO 902899L NO 90902899 A NO90902899 A NO 90902899A NO 902899 A NO902899 A NO 902899A NO 902899 L NO902899 L NO 902899L
Authority
NO
Norway
Prior art keywords
procedure
antigen
enzyme
solid phase
immunological analysis
Prior art date
Application number
NO90902899A
Other languages
English (en)
Other versions
NO902899D0 (no
NO178047B (no
NO178047C (no
Inventor
Yoji Marui
Chozo Hayashi
Shigeki Ito
Mieko Fujio
Hiroki Tanaka
Toshihide Nagasaki
Yasuji Soda
Hitoshi Kaneta
Original Assignee
Nippon Shoji Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26411503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO902899(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nippon Shoji Kk filed Critical Nippon Shoji Kk
Publication of NO902899D0 publication Critical patent/NO902899D0/no
Publication of NO902899L publication Critical patent/NO902899L/no
Publication of NO178047B publication Critical patent/NO178047B/no
Publication of NO178047C publication Critical patent/NO178047C/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57476—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofetal proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO902899A 1989-06-29 1990-06-28 Enzymbasert, immunologisk analyse for et antigen samt fast fase for anvendelse ved analysen NO178047C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16769789 1989-06-29
JP2070341A JP2619549B2 (ja) 1989-06-29 1990-03-20 抗原の定量法およびそれに用いる固相

Publications (4)

Publication Number Publication Date
NO902899D0 NO902899D0 (no) 1990-06-28
NO902899L true NO902899L (no) 1991-01-02
NO178047B NO178047B (no) 1995-10-02
NO178047C NO178047C (no) 1996-01-10

Family

ID=26411503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902899A NO178047C (no) 1989-06-29 1990-06-28 Enzymbasert, immunologisk analyse for et antigen samt fast fase for anvendelse ved analysen

Country Status (8)

Country Link
US (1) US5378608A (no)
EP (2) EP0620438A1 (no)
JP (1) JP2619549B2 (no)
DE (1) DE69021953T2 (no)
DK (1) DK0405578T3 (no)
ES (1) ES2078923T3 (no)
FI (1) FI101022B (no)
NO (1) NO178047C (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274325B1 (en) * 1990-06-25 2001-08-14 Boehringer Mannheim Gmbh Method for carrying out a homogeneous-immunoassay based on agglutination
JP2968039B2 (ja) * 1990-11-29 1999-10-25 株式会社京都第一科学 化学発光免疫測定法
DE4140142A1 (de) * 1991-12-05 1993-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim, De Multivalentes dextranreagenz zum einsatz in praezipitationstests
ES2051247B1 (es) * 1992-11-27 1994-12-16 Univ Cordoba Procedimiento para la deteccion y medida de los niveles de hormona luteotropica porcina.
US5747352A (en) * 1994-05-23 1998-05-05 Beckman Instruments, Inc. Reagents and methods for the rapid and quantitative assay of pharmacological agents
DE19530078A1 (de) * 1995-08-16 1997-02-20 Bayer Ag Optischer Festphasenbiosensor auf Basis von Streptavidin und Biotin
DE19534988A1 (de) * 1995-09-21 1997-03-27 Forssmann Wolf Georg Verfahren zur Herstellung und Anwendung synthetischer, biotinylierter Peptide
US5958704A (en) 1997-03-12 1999-09-28 Ddx, Inc. Sensing system for specific substance and molecule detection
US6303325B1 (en) 1998-05-29 2001-10-16 Dade Behring Inc. Method for detecting analytes
DE69931467T3 (de) 1998-11-06 2018-12-27 Lsi Medience Corporation Neue komplexe, die vernetztes avidin enthalten, verfahren zur herstellung und analyseverfahren, das diese verwendet
WO2002090961A2 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US20040209294A1 (en) * 2002-09-02 2004-10-21 National Food Research Institute Method to produce a receptor chip using biotinylated protein
AU2004210964A1 (en) * 2003-02-11 2004-08-26 University Of Washington Stimuli-responsive polymer conjugates and related methods
US20040248223A1 (en) * 2003-06-05 2004-12-09 Idexx Laboratories, Inc. Reduction of interfering peroxidase activity in peroxidase based detection methods
MX2009004354A (es) * 2006-11-01 2009-06-18 Beckman Coulter Inc Superficies de union para ensayos de afinidad.
US7981688B2 (en) 2007-03-08 2011-07-19 University Of Washington Stimuli-responsive magnetic nanoparticles and related methods
US8426214B2 (en) * 2009-06-12 2013-04-23 University Of Washington System and method for magnetically concentrating and detecting biomarkers
US20110117668A1 (en) * 2009-11-09 2011-05-19 University Of Washington Through Its Center For Commercialization Self-powered smart diagnostic devices
US9080933B2 (en) 2009-11-09 2015-07-14 University Of Washington Through Its Center For Commercialization Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
EP2560003B1 (en) 2010-04-14 2018-07-04 Eiken Kagaku Kabushiki Kaisha Complex of labeled probe and water-soluble carrier
US9588110B2 (en) 2011-07-28 2017-03-07 Cell Signaling Technology, Inc. Multi component antibody based detection technology

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE430062B (sv) * 1977-03-04 1983-10-17 Pharmacia Fine Chemicals Ab Kopplings- eller tioleringsreagens
JPS5510590A (en) * 1978-05-04 1980-01-25 Wellcome Found Enzyme immunity quantity analysis
US4282287A (en) * 1980-01-24 1981-08-04 Giese Roger W Biochemical avidin-biotin multiple-layer system
SE8003732L (sv) * 1980-05-19 1981-11-20 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
EP0072902B1 (de) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
US4434150A (en) * 1981-10-19 1984-02-28 Ortho Diagnostic Systems, Inc. Immunological reagents employing polymeric backbone possessing reactive functional groups
US4429008B1 (en) * 1981-12-10 1995-05-16 Univ California Thiol reactive liposomes
GB8307156D0 (en) * 1983-03-15 1983-04-20 Celltech Ltd Heterogeneous binding assays
US4496654A (en) * 1983-04-08 1985-01-29 Quidel Detection of HCG with solid phase support having avidin coating
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
AU7032787A (en) * 1986-02-06 1987-08-25 Microbiological Associates, Inc. Latex agglutination using avidin/biotin system
US4778751A (en) * 1986-05-12 1988-10-18 Diagnostic Products Corporation Method for measuring antigens or antibodies in biological fluids using ligand labeled antigens or ligand labeled antibodies
US4798795A (en) * 1987-02-17 1989-01-17 Hoechst Celanese Corporation Biotinylating agents
JPH07107537B2 (ja) * 1987-08-03 1995-11-15 イーストマン コダック カンパニー アビジン−及びビオチン−固定試薬，分析要素並びにその使用法
US4916075A (en) * 1987-08-19 1990-04-10 Ohmicron Corporation Differential homogeneous immunosensor device
JPS6488367A (en) * 1987-09-30 1989-04-03 Japan Chem Res Immobilized antibody
WO1990004786A1 (en) * 1988-10-17 1990-05-03 Molecular Devices Corporation Hapten derivatized capture membrane and diagnostic assays using such membrane

Also Published As

Publication number Publication date
NO902899D0 (no) 1990-06-28
NO178047B (no) 1995-10-02
DE69021953T2 (de) 1996-04-04
US5378608A (en) 1995-01-03
NO178047C (no) 1996-01-10
EP0620438A1 (en) 1994-10-19
FI903228A0 (fi) 1990-06-27
JP2619549B2 (ja) 1997-06-11
EP0405578A2 (en) 1991-01-02
JPH03128460A (ja) 1991-05-31
DK0405578T3 (da) 1995-09-18
EP0405578B1 (en) 1995-08-30
ES2078923T3 (es) 1996-01-01
FI101022B (fi) 1998-03-31
DE69021953D1 (de) 1995-10-05
EP0405578A3 (en) 1991-05-29

Similar Documents

Publication Publication Date Title
NO902899D0 (no) Fremgangsmaate for enzymbasert immunologisk analyse av et antigen samt fast fase for anvendelse ved fremgangsmaaten.
IL88248A (en) Solid phase immunoassay for detecting hiv antigens using kc-57 monoclonal antibody, and kit for the performance thereof
NO905644D0 (no) Anordning ved apparat samt fremgangsmaate for fremstillingputeliknende emballeringsmateriale.
BR8807567A (pt) Teste imuno-enzimatico simultaneo para a deteccao de antigeno e/ou anticorpo em humanos
NO915137D0 (no) Hittil ukjente antistoffer som er reaktive med humankarsinomer
AU4269589A (en) Assay and sensing means for determining analyte
DK113690A (da) Fremgangsmaade til fremstilling af bitumen-polymerpraeparater, samt ved fremgangsmaaden opnaaede saadanne praeparater
HK1033773A1 (en) An assay for detecting anti-hepatitis c virus and the kit therefor.
DE69019884D1 (de) Massenspektrometer zur Analyse von Stoffen.
AU4979290A (en) Reagent for immunoassay and device using the same
DK488387D0 (da) Fremgangsmaade til fremstilling af hydrolyseret lecithin samt anvendelse af det fremstillede produkt
NO900948L (no) Forbedret stroppskjoet samt fremgangsmaate for fremstillingav samme.
EP0307149A3 (en) Solid phase immunoassay for an antibody and biological constructions for use therein
EP0311383A3 (en) Monoclonal antibody to methamphetamine, preparation of the same, assay method and assay kit of methamphetamine
AU8944291A (en) Immunoassay for the determination of anti-hiv antibodies in human samples
AU9052491A (en) Assay device and method for antibody and antigen detection
NO180656C (no) Interferometeranordning samt anvendelse av denne
IL91414A0 (en) Reagents and methods for the determination of analytes
AU3829189A (en) Detecting antigens or antibodies
GB9211902D0 (en) Method of determining the allergenic response of a sample of mammalian blood to an antigen
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
DK116487D0 (da) Fremgangsmaade til eksponering af en epitop i et protein med bestemt polypeptidstruktur, samt vektorer til brug ved fremgangsmaaden, hybridproteiner omfattende epitopen, og anvendelse af hybridproteinet ved diagnoser.
NO159753C (no) Fremgangsm te ved kontinuerlig bestemmelse av vaeskeositet, samt anordten.
BR8803673A (pt) Hibridoma,mutantes,anticorpo,processos para a preparacao de um hidroma e para a preparacao de um anticorpo,processo para determinacao da existencia de antigeno e kit de teste
NO872646L (no) Cytorhodin s-derivater samt fremgangsmŸte for fremstilling av disse.